SCHEMBL2273887

SCHEMBL2273887

O=C(O)c1ccc(CCc2ccccc2)cc1NC(=O)c1csc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
NFATC1 O95644 1/20 0.48
PIN1 Q13526 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
PRSS12 P56730 4/20 0.46
HPGD P15428 3/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.46
C5AR1 P21730 1/20 0.45
RAB9A P51151 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5146865 0.82 ACLY (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1307335 0.82 GRIK1 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2267924 0.79 PRSS12 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2275929 0.79 KMT2A (0.62) HDAC1MEN1MAPTKMT2APLK1
SCHEMBL2270880 0.78 ALOX15 (0.60) HPGDALDH1A1LMNARAB9ANPC1
SCHEMBL2276277 0.77 NPC1 (0.54) HDAC3HDAC1SMN1; SMN2HPGDALDH1A1
SCHEMBL2277719 0.77 HDAC1 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2276434 0.77 RAB9A (0.55) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL2276177 0.77 SLC16A3 (0.55) SMN1; SMN2HPGDALDH1A1KDM4EPOLB
SCHEMBL2275852 0.77 MEN1 (0.55) HPGDALDH1A1LMNARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 HDAC3 87/4885HDAC4 96/4885HDAC1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.